We therefore analysed whether NFIB expression correlated with these subtypes using data from The Cancer Genome Atlas (TCGA) dataset of patient tumour tissue, classified as either proneural, neural, classical or mesenchymal GBM [25–27]. The gene discussed is NFIB; the disease is glioblastoma.